228 related articles for article (PubMed ID: 36879801)
1. Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease.
Gambardella J; Fiordelisi A; Cerasuolo FA; Buonaiuto A; Avvisato R; Viti A; Sommella E; Merciai F; Salviati E; Campiglia P; D'Argenio V; Parisi S; Bianco A; Spinelli L; Di Vaia E; Cuocolo A; Pisani A; Riccio E; Di Risi T; Ciccarelli M; Santulli G; Sorriento D; Iaccarino G
iScience; 2023 Mar; 26(3):106074. PubMed ID: 36879801
[TBL] [Abstract][Full Text] [Related]
2. The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions.
Vallée A; Lecarpentier Y; Vallée JN
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771718
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
4. Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma.
Li B; He L; Zuo D; He W; Wang Y; Zhang Y; Liu W; Yuan Y
J Cancer; 2017; 8(6):940-949. PubMed ID: 28529605
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Cell Dysfunction and Hypoxia as Potential Mediators of Pain in Fabry Disease: A Human-Murine Translational Approach.
Klug K; Spitzel M; Hans C; Klein A; Schottmann NM; Erbacher C; Üçeyler N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895103
[TBL] [Abstract][Full Text] [Related]
6. High-intensity interval training-induced metabolic adaptation coupled with an increase in Hif-1α and glycolytic protein expression.
Abe T; Kitaoka Y; Kikuchi DM; Takeda K; Numata O; Takemasa T
J Appl Physiol (1985); 2015 Dec; 119(11):1297-302. PubMed ID: 26429867
[TBL] [Abstract][Full Text] [Related]
7. TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.
Remels AH; Gosker HR; Verhees KJ; Langen RC; Schols AM
Endocrinology; 2015 May; 156(5):1770-81. PubMed ID: 25710281
[TBL] [Abstract][Full Text] [Related]
8. Loss of skeletal muscle HIF-1alpha results in altered exercise endurance.
Mason SD; Howlett RA; Kim MJ; Olfert IM; Hogan MC; McNulty W; Hickey RP; Wagner PD; Kahn CR; Giordano FJ; Johnson RS
PLoS Biol; 2004 Oct; 2(10):e288. PubMed ID: 15328538
[TBL] [Abstract][Full Text] [Related]
9. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells.
De Saedeleer CJ; Copetti T; Porporato PE; Verrax J; Feron O; Sonveaux P
PLoS One; 2012; 7(10):e46571. PubMed ID: 23082126
[TBL] [Abstract][Full Text] [Related]
10. A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1α and p53 activity in triple-negative breast cancer.
Du Y; Wei N; Ma R; Jiang S; Song D
Cell Death Dis; 2020 Sep; 11(9):731. PubMed ID: 32908121
[TBL] [Abstract][Full Text] [Related]
11. Fatigue as hallmark of Fabry disease: role of bioenergetic alterations.
Gambardella J; Riccio E; Bianco A; Fiordelisi A; Cerasuolo FA; Buonaiuto A; Di Risi T; Viti A; Avvisato R; Pisani A; Sorriento D; Iaccarino G
Front Cardiovasc Med; 2024; 11():1341590. PubMed ID: 38327490
[TBL] [Abstract][Full Text] [Related]
12. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells.
Lu J; Chen H; He F; You Y; Feng Z; Chen W; Li X; Zhao L
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1455-1463. PubMed ID: 32271958
[TBL] [Abstract][Full Text] [Related]
14. Hyperbaric Oxygen Therapy Represses the Warburg Effect and Epithelial-Mesenchymal Transition in Hypoxic NSCLC Cells
Zhang L; Ke J; Min S; Wu N; Liu F; Qu Z; Li W; Wang H; Qian Z; Wang X
Front Oncol; 2021; 11():691762. PubMed ID: 34367973
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q
Yang HL; Lin PY; Vadivalagan C; Lin YA; Lin KY; Hseu YC
Arch Toxicol; 2023 Apr; 97(4):1047-1068. PubMed ID: 36847822
[TBL] [Abstract][Full Text] [Related]
16. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
[TBL] [Abstract][Full Text] [Related]
17. Low skeletal muscle mass as an early sign in children with fabry disease.
Lu Z; Huang G; Yu L; Wang Y; Gao L; Lin L; Hu L; Mao J
Orphanet J Rare Dis; 2023 Jul; 18(1):199. PubMed ID: 37480128
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Warburg effect that arises in tumor cells expressing membrane type-1 matrix metalloproteinase.
Sakamoto T; Niiya D; Seiki M
J Biol Chem; 2011 Apr; 286(16):14691-704. PubMed ID: 21372132
[TBL] [Abstract][Full Text] [Related]
19. Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease.
Hamed A; DasMahapatra P; Lyn N; Gwaltney C; Hopkin RJ
Orphanet J Rare Dis; 2021 Jun; 16(1):285. PubMed ID: 34172077
[TBL] [Abstract][Full Text] [Related]
20. Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease.
Chou SJ; Yu WC; Chang YL; Chen WY; Chang WC; Chien Y; Yen JC; Liu YY; Chen SJ; Wang CY; Chen YH; Niu DM; Lin SJ; Chen JW; Chiou SH; Leu HB
Int J Cardiol; 2017 Apr; 232():255-263. PubMed ID: 28082092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
